Table 2.

Summary of the pooled risk ratios (RR) between the mavoglurant group and placebo group in all reported adverse events

Adverse event	N of RCTs	N patients	RR [95% CI]
Dizziness	5	471	4.19 [1.83 to 9.64]
Dyskinesia	6	585	0.74 [0.46 to 1.17]
Euphoria	3	73	3.70 [0.64 to 21.29]
Fatigue	5	471	2.11 [0.72 to 6.15]
Insomnia	4	426	1.90 [0.58 to 6.23]
Hallucination	2	211	4.55 [0.86 to 24.04]
Nausea	4	274	2.02 [0.48 to 8.46]

RCT, randomized controlled trial